Compugen Stock

Compugen Forward P/E

Delisted·Jun 15, 2026

The Forward P/E Ratio of Compugen (CGEN) as of Jul 18, 2026 is 5.64. In the previous year, Forward P/E Ratio was -14.02 — a change of -140.27% (higher).

Forward P/E

5.64

YoY

-140.27%

Last updated:

Forward P/E Ratio of Compugen is 2026 5.64 . Forward P/E Ratio of Compugen was 2025 -14.02 . It decreases by -140.27% higher compared to the previous year.
Access this data via the Eulerpool API

Compugen Stock analysis

What does Compugen do? Compugen Ltd is an Israeli biotechnology company focused on the development of therapeutics and diagnostic products. It was founded in 1993 and is headquartered in Tel Aviv. Compugen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compugen stock

Forward P/E Ratio of Compugen is 5.64 in 2026.

Access this data via the Eulerpool API

Valuation — Compugen

All Key Metrics — Compugen